NN
Nanobac Pharmaceuticals, Incorporated
NNBP · OTC
$0.00 +0.00% (+$0.00)
Market Cap 21.5K €
P/E Ratio 0.00x
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
95 /100
Cheap EV/EBITDA 2.00x
P/S 0.00x
P/B 0.00x
Growth
9 /100
Declining Book val. growth 3.29%
Rev. growth 33.29%
FCF growth N/A
Profitability
82 /100
Strong Net margin 9.35%
Op. margin 22.27%
Gross margin 45.07%
Quality
60 /100
Average ROA 5.92%
Asset turnover 0.63x
ROIC 11.66%
Debt
41 /100
Moderate Current ratio 1.12x
Int. coverage 3.73x
Net debt/EBITDA 2.00x
Stability
44 /100
Moderate Rev. volatility 22.18%
Profitable years 1
Beta -8.83x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre NNBP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Stanton
Employees
1
Headquarters
Tampa